Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Tollkuci A"'
Autor:
Tollkuci, Eris1,2, Chalmers, Anna3, Schultz, Kathryn4, Basu, Sanjib5, Dewdney, Summer6, Usha, Lydia7
Publikováno v:
Journal of Hematology Oncology Pharmacy. Apr2020, Vol. 10 Issue 2, p65-72. 8p.
Autor:
Rebecca Myers, Eris Tollkuci
Publikováno v:
Journal of Oncology Pharmacy Practice. 27:1792-1794
Introduction Citrobacter bacteria are gram-negative anaerobic bacilli commonly found in water, soil, food, and the intestinal tracts of animals and humans. Patients at highest risk of these nosocomial infections include neonates and adults who are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dffe5db207d0e1d163cebc13ab32e45
https://doi.org/10.1177/10781552211001423
https://doi.org/10.1177/10781552211001423
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(5)
Introduction Gilteritinib is a multitargeted tyrosine kinase inhibitor (TKI) approved by the Food and Drug Administration (FDA) for acute myeloid leukemia (AML) with a FMS-related tyrosine kinase 3 (FLT3) mutation. The pharmacokinetics of gilteritini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cd5393c0d3502251cd79e77cb107ff0
https://pubmed.ncbi.nlm.nih.gov/33175659
https://pubmed.ncbi.nlm.nih.gov/33175659
Autor:
Amanda N. Seddon, Paul Fitzpatrick, Rebecca Myers, Eris Tollkuci, Celalettin Ustun, Sunita Nathan
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(8)
Introduction Acute graft-versus-host disease (aGVHD) is a significant immune-mediated complication of allogeneic hematopoietic stem cell transplant (HSCT). Despite prophylactic immunosuppression, the incidence of grades II–IV aGVHD post-HSCT varies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db90a9197b378b42c5db762ea1191fe4
https://pubmed.ncbi.nlm.nih.gov/32356680
https://pubmed.ncbi.nlm.nih.gov/32356680
Publikováno v:
Journal of Oncology Pharmacy Practice. 25:1285-1288
Midostaurin is a multitargeted tyrosine kinase inhibitor approved by the Food and Drug Administration for FMS-related tyrosine kinase 3-positive acute myeloid leukemia in combination with standard daunorubicin and cytarabine induction and high-dose c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3da43aed1a5e1d90ea496ab5d096fde
https://doi.org/10.1177/1078155218801067
https://doi.org/10.1177/1078155218801067
Autor:
Jacqueline Baptista, Debra A. Marinovic, Armin Rashidi, Eris Tollkuci, Ece Mutlu, Mallory Weber, Shernan G. Holtan, Marisa Mozer, Daniel J. Weisdorf, Celalettin Ustun, Sunita Nathan
Publikováno v:
Bone Marrow Transplantation. 55:833-835
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9798f7961f04f9f177c30336b0124fd0
https://doi.org/10.1038/s41409-019-0630-1
https://doi.org/10.1038/s41409-019-0630-1
Autor:
Hyun Don Yun, Mohammad Junaid Hussain, Gizem Yassa, Ankur Varma, Celalettin Ustun, Jacqueline Baptista, Becca Myers, Sunita Nathan, Sarah Ziny, Kathryn A McDonnell, Eris Tollkuci, Anu Kadanagowd, Mogboluwaga Oginni, Debra A. Marinovic
Publikováno v:
Transplantation and Cellular Therapy. 27:S367-S368
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9cf3838535a2be6f91eaac81f45c9024
https://doi.org/10.1016/s2666-6367(21)00472-3
https://doi.org/10.1016/s2666-6367(21)00472-3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Celalettin, Ustun, Jacqueline, Baptista, Debra A, Marinovic, Eris, Tollkuci, Marisa, Mozer, Armin, Rashidi, Mallory, Weber, Ece, Mutlu, Shernan, Holtan, Daniel, Weisdorf, Sunita, Nathan
Publikováno v:
Bone marrow transplantation. 55(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::95912282c11434de7a1ef8c209b28d0a
https://pubmed.ncbi.nlm.nih.gov/31358917
https://pubmed.ncbi.nlm.nih.gov/31358917
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.